BioSpace News Archive

Kintara Therapeutics, Inc. today announced that a multiyear research grant from Luxembourg National Research Fund (FNR) and Cancer Foundation Luxembourg has been awarded to Doctor Anna Golebiewska Ph.D.

OncoHost today announced results from its ongoing multicenter clinical trial, PROPHETIC.

Transcenta Holding Limited announces that the TST001 US Phase I Trial has been selected as a Trial in Progress poster presentation at the 2022 ASCO GI conference from January 20 to 22, 2022 in San Francisco, CA; and the TST001 China Phase I trial data as a poster presentation at the International Gastric Cancer Congress, from March 6 to 9, 2022 in Houston, TX.

Sirona Biochem Corp. is pleased to announce sponsorship of the French Fluorine Chemistry Symposium which will take place in Normandy, France, May 16-19, 2022 in Forges-les-Eaux.

On January 10, 2022, the tri-agencies, Department of Labor (DOL), Health and Human Services (HHS) and Treasury issued new guidance that supports women’s access to U.S. Food and Drug Administration (FDA) approved contraceptive products.

Travere Therapeutics, Inc. announced that on January 10, 2022, the Compensation Committee of its Board of Directors granted inducement equity grants covering an aggregate of 42,000 shares of its common stock to five new employees, consisting of inducement stock options to purchase an aggregate of 33,000 shares of common stock and inducement restricted stock units, or RSUs, covering an aggregate of 9,000 shares of its common stock.

Tevogen Bio, a clinical stage biotechnology company specializing in cell and gene therapies in oncology and viral infections, today announced that the U.S. Patent and Trademark Office (USPTO) has granted a new patent (No. 11,219,684) for the method of preparing COVID-19 peptide specific cytotoxic T cells (CTLs) for the treatment of COVID-19 infection.

Doheny Eye Institute, a global leader in vision research and basic science to save human eyesight, has announced that Deborah Ferrington, PhD, is joining the organization as Chief Scientific Officer.

In nephrolithiasis or kidney stone disease, the patient develops calculi from chemicals such as calcium oxalate, which precipitate out of urine within the renal pelvis and the tubular lumen.

The hospital surgical disinfectant market has been expected to grow at a noticeable speed in the upcoming years.